Download PDF
Pharmacopsychiatry 2015; 48(07): 296
DOI: 10.1055/s-0035-1565223
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Retrospective Analysis of Therapeutic Drug Monitoring Data for Treatment of Bipolar Disorder with Lamotrigine

S. Unholzer
1   Klinische Pharmakologie am Lehrstuhl mit Poliklinik für Psychiatrie und Psychotherapie und am Lehrstuhl für Pharmakologie und Toxikologie der Universität Regensburg/Germany
,
E. Haen
1   Klinische Pharmakologie am Lehrstuhl mit Poliklinik für Psychiatrie und Psychotherapie und am Lehrstuhl für Pharmakologie und Toxikologie der Universität Regensburg/Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
02 December 2015 (online)

Also available at
 
 PDF Download Permissions and Reprints

Correction to:

Retrospective Analysis of Therapeutic Drug Monitoring Data for Treatment of Bipolar Disorder with LamotriginePharmacopsychiatry 2015; 25(06): 211-214
DOI: 10.1055/s-0035-1559635


#

Erratum

Retrospective Analysis of Therapeutic Drug Monitoring Data for Treatment of Bipolar Disorder with Lamotrigine

S. Unholzer, E. Haen

Pharmacopsychiatry 2015; 48: 211–214

DOI: 10.1055/s-0035-1559635

Dear reader,
there was a misunderstanding in our article. In the discussion (page 213, second paragraph, lines 6–7) we stated that “Kagawa et al. even suggested a lamotrigine concentration above 12,700 ng/mL”. But the unit in their article is μmoL/L. 12.7 μmoL/L is equal to 12,700 nmol/L which is equal to 3252 ng/ml. This supports our findings that lower lamotrigine serum concentrations lead to a therapeutic effect.
Kind regards
Sandra Unholzer


#
#
   Permissions and Reprints